with B-12 Tablets IP 1 mg + 0.5 mg + 1.0 mg Exporter

with B-12 Tablets IP 1 mg + 0.5 mg + 1.0 mg Exporter in India – Healthy Inc

with B-12 Tablets IP 1 mg + 0.5 mg + 1.0 mg Exporter product packaging

with B-12 Tablets IP 1 mg + 0.5 mg + 1.0 mg | Exporter

Product image for with B-12 Tablets IP 1 mg + 0.5 mg + 1.0 mg Exporter; regulatory dossiers & international shipping.

Product Information

Generic Namewith B-12
ManufacturerHealthy Life Pharma Pvt. Ltd.
HSN Code30049099
PharmacopoeiaIP
Product TypeTablet
CategoryVitamin and Mineral Supplements
SubcategoryVitamin and Mineral Supplements
Active Ingredientwith B-12
Strength1 mg + 0.5 mg + 1.0 mg
Dosage FormTablet
Pack Size10 x 10 Tablets / Box (Alu-Alu / Blister)
Route of AdministrationOral
Prescription RequiredYes
Therapeutic CategoryVitamin and Mineral Supplements

Medicine Details & Safety

Short DescriptionHealthy Inc invites international procurement enquiries for with B-12 Tablets IP 1 mg + 0.5 mg + 1.0 mg manufactured by Healthy Life Pharma. Importers and overseas distributors can submit destination-country requirements for assessment of registration documentation, export artwork and shipment feasibility.
Approved Uses / Indications1. Prevention and treatment of clinical vitamin and mineral deficiency states. 2. Nutritional supplementation during convalescence, increased physiological demand, pregnancy, and geriatric care.
Full Description

Healthy Inc invites international procurement enquiries for with B-12 Tablets IP 1 mg + 0.5 mg + 1.0 mg manufactured by Healthy Life Pharma. Importers and overseas distributors can submit destination-country requirements for assessment of registration documentation, export artwork and shipment feasibility.

Product technical specifications

Generic namewith B-12
Compositionwith B-12
Strength1 mg + 0.5 mg + 1.0 mg
CategoryVitamin and Mineral Supplements
PharmacopoeiaIP
Dosage formTablet

Product technical specifications

Generic nameAcarbose
CompositionAcarbose
Strength25 mg
CategoryAntidiabetic Drugs
PharmacopoeiaUSP / IP
Dosage formTablet

Export regulatory and dossier readiness

Identify the destination authority and registration pathway. Request confirmation of CTD or ACTD dossier availability, COPP, Free Sale Certificate and current GMP documentation as applicable. Confirm COA and analytical files for the proposed product and market.

Climatic zone stability and export artwork

For with B-12 Tablets IP 1 mg + 0.5 mg + 1.0 mg, request stability evidence appropriate to the importing market, including Zone IVb where required. Confirm shelf life, storage conditions and multilingual carton, blister and leaflet artwork against approved documentation.

Global logistics and trade terms

Specify the destination, shipment size and required delivery window. Evaluate air freight or LCL/FCL sea freight from Mumbai where feasible. Agree EXW, FOB, CIF or CIP as appropriate to the transport mode and contract; confirm freight, insurance and customs responsibilities.

International buyer requirements

Enquiries may identify Africa, LATAM, Middle East, CIS or APAC as target regions. Market authorization, import permits, document availability and shipment acceptance must be confirmed for each country; this is not a statement of existing registrations.
Dosage InstructionsAdminister orally once daily with meals, or as recommended by the healthcare provider. Swallow whole with water; do not exceed the recommended dietary intake.
Side EffectsCommon: Mild gastrointestinal fullness, transient dark stools (with iron), mild nausea. Uncommon: Diarrhea, mild skin flushing, headache. Rare: Allergic hypersensitivity reactions, hypervitaminosis from excessive chronic intake.
Warnings and PrecautionsRecommended Allowances: Do not consume in doses exceeding upper tolerable limits without clinical oversight. Renal Compromise: Exercise caution with fat-soluble vitamins or mineral supplements in severe renal impairment. Keep safely out of reach of children.
Contraindications1. Known hypersensitivity to any vitamin or active mineral ingredient in the tablet.
2. Preexisting hypervitaminosis or hypercalcemia.
3. Severe renal stone disease (for high-dose calcium/ascorbic acid combinations).
Drug Interactions1. Tetracyclines & Fluoroquinolones: Chelation with divalent/trivalent minerals reduces antibiotic absorption; separate by 2 hours.
2. Antiepileptics (Phenytoin): Folate co-administration may alter serum anticonvulsant levels.
3. Levodopa: High doses of pyridoxine may diminish levodopa therapeutic antiparkinsonian response.

Frequently Asked Questions

QuestionAnswer
Which registration documents can be requested for with B-12 Tablets IP 1 mg + 0.5 mg + 1.0 mg?Specify CTD/ACTD, COPP, FSC, COA and stability requirements for availability review.
Is Zone IVb data available for with B-12 Tablets IP 1 mg + 0.5 mg + 1.0 mg?Request confirmation for the exact formulation and packaging configuration.
Can export artwork be multilingual for with B-12 Tablets IP 1 mg + 0.5 mg + 1.0 mg?Provide the required languages and approved regulatory artwork for review.
Which shipping terms can be discussed for with B-12 Tablets IP 1 mg + 0.5 mg + 1.0 mg?EXW, FOB, CIF and CIP may be evaluated according to shipment mode and agreement.
How do I obtain an export quotation for with B-12 Tablets IP 1 mg + 0.5 mg + 1.0 mg?Provide destination country, quantity, documentation requirements and preferred trade terms.

Product Tags

with B-12 Tablets IP 1 mg + 0.5 mg + 1.0 mg Exporterwith B-12 1 mg + 0.5 mg + 1.0 mgRegulatory Dossiers & International ShippingHealthy Inc

Product Hashtags

#with#Exporter#PharmaB2B

Related Products

Latest Posts